Novocure earnings were -$164.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NVCR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$34.3M, down 47.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NVCR reported annual earnings of -$168.6M, with -18.6% growth. The next NVCR earnings date is Jun 5, 2025.
On NVCR's earnings call on Invalid Date, Novocure (NASDAQ: NVCR) reported Q1 2025 earnings per share (EPS) of -$0.31, up 13.89% year over year. Total NVCR earnings for the quarter were -$34.32 million. In the same quarter last year, Novocure's earnings per share (EPS) was -$0.36.
The next NVCR earnings date is Invalid Date. Add NVCR to your watchlist to be reminded of Novocure's next earnings date.
Is Novocure profitable or losing money?
As of the last Novocure earnings report, Novocure is currently losing money. Novocure's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$164.19 million, a 14.82% decrease year over year.
What was NVCR's earnings growth in the past year?
As of Novocure's earnings date in Invalid Date, Novocure's earnings has grown year over year. NVCR earnings in the past year totalled -$164.19 million.
What are Novocure's earnings expectations?
The current EPS estimate for Novocure's earnings report in Invalid Date is -$0.46.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.